Skip to main content
. 2017 Aug 7;22(1):4–15. doi: 10.1111/jcmm.13293

Table 2.

Summary of clinical correlations between dysregulated Hippo pathway components and bladder cancer

Hippo pathway component Role in bladder cancer development References
MST1/2 MST1/2 and RUNX3 collaborate and mediate BC cell death 132, 133, 134
RUNX3 Complicated interaction among MST1/2, RUNX3 and SAV1 deregulate the YAP‐TEAD activity and is crucial in BC cell proliferation and apoptosis
LATS1 Remarkably low level in BC tissues 131
Alterations of single base pairs in this gene are observed
Mask2 Mask 2 is required for YAP‐induced BC cell growth and migration 89
YAP1 Elevated YAP1 expression significantly associates with poor clinicopathologic stage and adverse patient survival 14, 15
Further, YAP1 expression is inversely correlated with chemotherapy sensitivity 142
TAZ TAZ together with YAP1 protect KLF5 from degradation in BC 137
Knockdown of KLF5 induces BC cell apoptosis